and yet another potential application for the BOS anti bacterial compoundjust one commercial product should see a strong rerating of BOS spmaybe worth a punt for a longer timeframe speccie
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025